Syon Capital’s Veracyte VCYT Stock Holding History

Syon Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,354	Closed	-$212K	–	661
2024 Q4	$212K	Buy	+5,354	New	+$203K	0.02%	504

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Syon Capital's VCYT Position: Q1 2025 in Review

Syon Capital sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 5,354 shares — an estimated $212K sold.

Syon Capital first reported a position in VCYT in Q4 2024 and held it in 1 quarter. The position peaked at $212K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

Syon Capital reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 5,354 Veracyte shares in Q1 2025, an estimated $212K.
Syon Capital first reported a position in Veracyte in Q4 2024 and held it in 1 quarter.
Syon Capital's Veracyte position peaked at $212K in Q4 2024.
287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.